Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.
Etoposide, a topoisomerase 2 (TOP2) inhibitor, is associated with the development of KMT2A (MLL)-rearranged infant leukemia. An epidemiological study suggested that in utero exposure to TOP2 inhibitors may be involved in generation of KMT2A (MLL) rearrangement. The present study examined the mechani...
Main Authors: | Mai Nanya, Masaki Sato, Kousuke Tanimoto, Minoru Tozuka, Shuki Mizutani, Masatoshi Takagi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4686171?pdf=render |
Similar Items
-
Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL
by: Huining Kang, et al.
Published: (2018-08-01) -
Acute Lymphoblastic Leukemia at Birth with KMT2A Gene Rearrangement
by: Sanjeev Kumar Jha, et al. -
PB1799: KMT2A-REARRANGED PEDIATRIC ACUTE MYELOID LEUKEMIA
by: E. Zerkalenkova, et al.
Published: (2022-06-01) -
Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias
by: Bruno A. Lopes, et al.
Published: (2022-06-01) -
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements
by: Ghayas C. Issa, et al.
Published: (2021-09-01)